J. Sandate

Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents.

D. Maahs, R. Kolotkin, D. Schade, 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Essure® Sterilization with Sonographic Confirmation Test: Protocol Description and Clinical Outcomes Using Ultrasound as an Essure Confirmation Test

H. Chapa, J. Sandate, L. Silver, 2011 .

Peritoneal adhesion prevention at cesarean section: an analysis of the effectiveness of an absorbable adhesion barrier.

H. Chapa, J. Sandate, L. Silver, 2011, The Journal of reproductive medicine.

In-office endometrial ablation using a third-generation uterine balloon therapy system: 12-month prospective follow-up on menstrual patterns and dysmenorrhea impact.

H. Chapa, J. Sandate, G. Venegas, 2009, The Journal of reproductive medicine.

In-office endometrial ablation and clinical correlation of reduced menstrual blood loss and effects on dysmenorrhea and premenstrual symptomatology.

H. Chapa, J. Sandate, G. Venegas, 2009, The Journal of reproductive medicine.

Three-Year Prospective Menstrual and Dysmenorrhea Outcomes after ThermachoiceIII® in-Office Therapy

H. Chapa, J. Sandate, G. Venegas, 2012 .

Menstrual and Dysmenorrhea Outcomes After Thermachoice III: A 2-Year Prospective Study

H. Chapa, J. Sandate, G. Venegas, 2010 .

Office Versus Hospital Based Essure® Procedure: Pareto Principle in Action

H. Chapa, J. Sandate, A. Antonetti, 2012 .

Incidence of de Novo Pelvic Pain After Radiofrequency or Thermal Balloon Global Endometrial Ablation Therapy

H. Chapa, J. Sandate, L. Silver, 2011 .

In-Office Thermachoice III Ablation: A Comparison of Two Anesthetic Techniques

H. Chapa, J. Sandate, G. Venegas, 2009, Gynecologic and Obstetric Investigation.

Emergent thermal balloon ablation for acute uterine hemorrhage: a report of 2 cases.

H. Chapa, J. Sandate, L. Silver, 2010, The Journal of reproductive medicine.